Ansong Raises ￥100M in Series A Funding Round

(VCBeat) Mar. 10, 2021 -- Recently, Beijing Ansong Technology Co., Ltd. ("Ansong"), a leading orthopedic implant manufacturer in China, announced the completion of a Series B round of more than 100 million yuan, led by HM Capital, with participation from Cowin Capital, Shining Capital and Decai Capital. WinX Capital served as the exclusive financial adviser for the latest round.

Founded in 2017, Ansong focuses on R&D, production and sales in the field of artificial joints, with the most excellent domestic R&D team of ceramic materials. It is the only Chinese orthopedic device company at the same time grasp the production technology of both zirconia and alumina ceramics. The company's independent R&D of ceramic hip implants has broken the monopoly of foreign manufacturers and filled the domestic gap.

Mr. Zhang Jifeng, chairman of Ansong, said, "Ansong is an innovative orthopedic device manufacturer driven by technology. Since its establishment, our team has overcome many difficulties and gradually built up outstanding technical advantages and strong technical barriers. In the future, we will continue to take root in the field of orthopedics, and continue to focus on improving the quality of life for patients. Through technological innovation, we are committed to providing better treatment options for doctors and patients around the world."

HM Capital, a Hillhouse Capital Group affiliated investment firm, focuses on healthcare investment. HM Capital is committed to building an investment platform with a global view and local execution to help early and growth-stage healthcare companies achieve accelerated development by leveraging the ecosystems of affiliated operating companies, the top-tier Asian private equity firm, and the premier international healthcare institution.

Cowin Capital Group was established in 2000  and has invested more than 300 companies, of which 60 more became public companies, and 150 more successfully exit. It focuses on investing in pioneering enterprises with steady developmenton long-term basis.